Academic Radiology
Volume 16, Issue 10 , Pages 1215-1222 , October 2009

Early Detection of Local RFA Site Recurrence Using Total Liver Volume Perfusion CT: Initial Experience

  • Martijn R. Meijerink, MD

      Affiliations

    • Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to: M.R.M.
    • ,
  • Jan Hein T.M. van Waesberghe, MD, PhD

      Affiliations

    • Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Lineke van der Weide, BSc

      Affiliations

    • Master of Oncology Program, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Petrousjka van den Tol, MD, PhD

      Affiliations

    • Department of Surgical Oncology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Sybren Meijer, MD, PhD

      Affiliations

    • Department of Surgical Oncology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Emile F. Comans, MD, PhD

      Affiliations

    • Department of Nuclear Medicine & PET Research, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Richard P. Golding, MD

      Affiliations

    • Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    • ,
  • Cornelis van Kuijk, MD, PhD

      Affiliations

    • Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands

Received 29 October 2008 ,Accepted 30 March 2009.

References 

  1. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1–8
  2. de Baere T. Radiofrequency ablation of the liver. AJR Am J Roentgenol. 2001;177:1213–1215
  3. Leen E, Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surg Oncol. 2007;16:47–51
  4. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  5. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003;12:243–255
  6. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825
  7. Donckier V, Van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol. 2003;84:215–223
  8. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol. 2006;16:80–87
  9. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol. 2004;11:215–223
  10. Miles KA, Hayball M, Dixon AK. Colour perfusion imaging: a new application of computed tomography. Lancet. 1991;337:643–645
  11. Meijerink MR, van Waesberghe JH, van der Weide L, van den Tol P, Meijer S, van Kuijk C. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345–2354
  12. Tsushima Y, Funabasama S, Sanada S, Aoki J, Endo K. Development of perfusion CT software for personal computers. Acad Radiol. 2002;9:922–926
  13. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology. 1997;205:716–720
  14. Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol. 1998;71:276–281
  15. Meijerink MR, van Cruijsen H, Hoekman K, et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol. 2007;17:1700–1713

PII: S1076-6332(09)00258-X

doi: 10.1016/j.acra.2009.03.023

Academic Radiology
Volume 16, Issue 10 , Pages 1215-1222 , October 2009

Article Tools

* Image Usage & Resolution